Matthew Quigley
Managing Director
Matthew Quigley is the Miami-based managing director for TrialGraphix. Mr. Quigley has almost two decades of experience leveraging cutting-edge technology to conceptualize and depict themes specifically related to patent litigation, including coronary artery animations to demonstrate the impact of a drug-eluting stent, interactive three-dimensional modeling of drug compositions, and digital time lines that explain developments in drug therapy. In his 17 years with TrialGraphix, he has worked on a variety of pharmaceutical disputes over Paxil and Flomax, among other drugs, including the following cases:
-
SmithKline Beecham Corp., et al. v. Apotex Corp., Apotex Inc., and TorPharm, Inc.
-
Astellas Pharma, Inc., et al. v. Ranbaxy Inc., et al.
-
Chiron Corp. v. Centocor, Inc. and Abbott Laboratories
“My experience with patent cases provides me with excellent insight into proper methods for educating jurors and judges on complex matters,” says Quigley.